Viral Hepatitis C - euro adhoc: Intercell AG / Financial Figures

euro adhoc: Intercell AG / Financial Figures
VWDNews - Vienna (Austria), March 6, 2006 - Vaccine company Intercell AG (VSE: ICLL) today announced its preliminary 2005 full year results. Intercell?s aggregate annual revenues increased from EUR 4.6 million in 2004 to EUR 8.5 million in 2005, or by 84.9

Highlights of rising and falling U.S. stocks
Investors Business Daily - Advanta Corp. ( ADVNA ) raised its regular quarterly dividends to 21.25 cents from 11.34 cents on Class A common stock. The Spring House, Pa., banking company also raised the dividend on Class B common shares to 25.5 cents from 13.61 cents. The

Novelos Therapeutics Closes $15 Million Private Placement
Genetic Engineering News - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, announced that today, it closed its previously announced private placement resulting in $15.06 million in